What does Korsana Biosciences, Inc. do?
Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of…
What is Korsana Biosciences, Inc.'s P/E and P/B ratio?
Korsana Biosciences, Inc. has a P/E ratio of -4.7 and a P/B ratio of -44.82.
What is Korsana Biosciences, Inc.'s debt-to-equity ratio?
Korsana Biosciences, Inc. has a debt-to-equity ratio of 0.01.
How much does Korsana Biosciences, Inc. owe compared with what it owns?
Korsana Biosciences, Inc. owes $1.22 for every $1 it owns (balance sheet Dec 2025), which means it owes more than it owns.
What is Korsana Biosciences, Inc.'s Positivity rank?
Korsana Biosciences, Inc. is ranked #6,669 of 6,775 companies globally and #3,904 of 4,000 in United States on PositoAI, with a Positivity Score of -40,974.
Does Korsana Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Korsana Biosciences, Inc..
Where can I read the latest news about Korsana Biosciences, Inc.?
Recent headlines about Korsana Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Korsana Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Korsana Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.